Jacobi Capital Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Jacobi Capital Management’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-936	Closed	-$28K	–	1432
2021 Q3	$28K	Hold	936	–	–	﹤0.01%	784
2021 Q2	$27K	Buy	+936	New	+$29.2K	﹤0.01%	767

Other funds holding ZEAL

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Jacobi Capital Management's ZEAL Position: Q4 2021 in Review

Jacobi Capital Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2021, closing a stake of 936 shares — an estimated $28K sold.

Jacobi Capital Management first reported a position in ZEAL in Q2 2021 and held it in 2 quarters. The position peaked at $28K in Q3 2021. 12 funds tracked by Wall St. Rank hold ZEAL as of Q4 2021.

Jacobi Capital Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 936 Zealand Pharma A/S American Depositary Shares shares in Q4 2021, an estimated $28K.
Jacobi Capital Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q2 2021 and held it in 2 quarters.
Jacobi Capital Management's Zealand Pharma A/S American Depositary Shares position peaked at $28K in Q3 2021.
12 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.